Bullish Stock

Investors Cheer as AbbVie (NYSE: ABBV) Announces Multi-Billion Dollar Purchase of ImmunoGen

Biopharmaceutical giant AbbVie (NYSE: ABBV) has agreed to acquire ImmunoGen (NASDAQ: IMGN) in a blockbuster deal worth $10.1 billion, sending IMGN stock skyrocketing. Under the terms of the sale agreement, AbbVie will purchase all outstanding shares of ImmunoGen at a […]

Investors Cheer as AbbVie (NYSE: ABBV) Announces Multi-Billion Dollar Purchase of ImmunoGen Read More ยป